3.0.0 3342 2022-02-09T02:44:08Z 2022-02-09T09:30:59Z Senate S 2020-02-27 116 ssju00 Judiciary Committee Senate Standing Referred to 2020-02-27T17:11:26Z Stopping Overdoses of Fentanyl Analogues Act 116 1622 S 2019-05-22 Read twice and referred to the Committee on the Judiciary. Related bill CRS Stopping Overdoses of Fentanyl Analogues Act 116 2935 HR 2019-06-28 Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. Related bill CRS Federal Initiative to Guarantee Health by Targeting Fentanyl Act 116 5771 HR 2020-02-06 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Related bill CRS Federal Initiative to Guarantee Health by Targeting Fentanyl Act 116 2701 S 2019-10-24 Read twice and referred to the Committee on the Judiciary. Related bill CRS A bill to amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances. 116 3148 S 2020-01-03 Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 398. Related bill CRS 2020-02-27 ssju00 Judiciary Committee Senate Read twice and referred to the Committee on the Judiciary. IntroReferral 2020-02-27 Introduced in Senate IntroReferral 10000 9 Library of Congress C001095 Sen. Cotton, Tom [R-AR] Tom Cotton R AR N L000594 Sen. Loeffler, Kelly [R-GA] Kelly Loeffler R GA 2020-02-27 True B001243 Sen. Blackburn, Marsha [R-TN] Marsha Blackburn R TN 2020-02-27 True Crime and Law Enforcement Border security and unlawful immigration Criminal procedure and sentencing Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Marketing and advertising Crime and Law Enforcement 00 2020-02-27 Introduced in Senate 2021-05-17T12:22:10Z Zero Tolerance for Deceptive Fentanyl Trafficking Act

This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Additionally, the bill establishes a new criminal offense and penalties with respect to the deceptive sale of fentanyl, fentanyl analogues, or fentanyl-related substances.

]]> Zero Tolerance for Deceptive Fentanyl Trafficking Act Display Title Zero Tolerance for Deceptive Fentanyl Trafficking Act Short Title(s) as Introduced Zero Tolerance for Deceptive Fentanyl Trafficking Act Introduced in Senate IS Official Title as Introduced A bill to amend the Controlled Substances Act to prohibit the deceptive sale of fentanyl, and for other purposes. Introduced in Senate IS Introduced in Senate 2020-02-27T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s3342is/xml/BILLS-116s3342is.xml 2020-02-27 Read twice and referred to the Committee on the Judiciary. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.